J. Thomas LaMont

Clostridium difficile toxin A perturbs cytoskeletal structure and tight junction permeability of cultured human intestinal epithelial monolayers.

Gail Hecht, C Pothoulakis, J. Thomas LaMont et al. · Journal of Clinical Investigation · 1988 · 392 citations · Full text

Life Sciences, Cell Biology, Microbiology +17

Clostridium difficile toxin B is more potent than toxin A in damaging human colonic epithelium in vitro.

Martin Riegler, Roland Sedivy, Charalabos Pothoulakis et al. · Journal of Clinical Investigation · 1995 · 345 citations · Full text

Life Sciences, Pathobiology, Mechanisms Of Toxicity +13

Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum

Charalabos Pothoulakis, Ciarán P. Kelly, Manher Joshi et al. · Gastroenterology · 1993 · 285 citations

Life Sciences, Infectious Diseases, Pharmacology +17

CP-96,345, a substance P antagonist, inhibits rat intestinal responses to Clostridium difficile toxin A but not cholera toxin.

C Pothoulakis, Ignazio Castagliuolo, J. Thomas LaMont et al. · Proceedings of the National Academy of Sciences · 1994 · 277 citations

Life Sciences, Immunology, Pharmacology +17

Intravenous immunoglobulin therapy for severe <i>Clostridium difficile</i> colitis

José R. Salcedo, Sarah Keates, C Pothoulakis et al. · Gut · 1997 · 265 citations · Full text

Life Sciences, Immunology, Pharmacology +17